MEDS ▼ -1.4% - DataMEDS AI, Inc.
$MEDS - DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
16-OCT-2026 06:00 AM ET
Share this post
More filings for $MEDS
MEDS ▼ -4.3% - DataMEDS AI, Inc.Oct 14, 2026MEDS ▲ +9.4% - DataMEDS AI, Inc.Oct 12, 2026MEDS ▲ +4.1% - DataMEDS AI, Inc.Oct 5, 2026MEDS ▲ +61.1% - DataMEDS AI, Inc.Oct 1, 2026MEDS ▲ +13.5% - DataMEDS AI, Inc.Sep 28, 2026MEDS ▲ +1.7% - DataMEDS AI, Inc.Sep 25, 2026
View full $MEDS filing history →💬 Comments
Loading comments…
Leave a comment